PT  - JOURNAL ARTICLE
AU  - Irene Volonghi
AU  - Sarah T Pendlebury
AU  - Sarah J V Welch
AU  - Ziyah Mehta
AU  - Peter M Rothwell
TI  - Cognitive outcomes after acute coronary syndrome: a population based comparison with transient ischaemic attack and minor stroke
AID  - 10.1136/heartjnl-2013-304207
DP  - 2013 Oct 15
TA  - Heart
PG  - 1509--1514
VI  - 99
IP  - 20
4099  - http://heart.bmj.com/content/99/20/1509.short
4100  - http://heart.bmj.com/content/99/20/1509.full
SO  - Heart2013 Oct 15; 99
AB  - Objective Acute coronary syndrome (ACS) is associated with increased risk of cognitive decline when compared with controls, but case:control studies are subject to selection bias. We therefore compared cognitive outcomes in ACS with transient ischaemic attack (TIA) and minor stroke, diseases with similar risk factor burden generally considered to be at high risk of cognitive decline. Design Prospective population based cohort study Setting Oxford Vascular Study (OXVASC) carried out within a defined population of 91 000 in Oxfordshire, UK. Patients 614 in total: 216 ACS, 182 TIA, 216 minor (non-disabling) stroke. Outcome measures Mini-Mental-State-Examination (MMSE), Telephone Interview for Cognitive Status-modified (TICSm), and Montreal Cognitive Assessment (MoCA) at 1 and 5 years. Results Overall risk factor burden was similar across groups but ACS patients had more smoking (27% vs 14%, p<0.001) and less hypertension (45% vs 53%, p<0.01) and atrial fibrillation (6% vs 14%, p<0.001). Cognitive outcomes were worse at 1 year in ACS versus TIA patients: mean±SD MMSE 26.6±2.7 vs 27.6±2.5, p<0.0001; OR=2.14, 95% CI 1.11 to 4.13 for moderate/severe cognitive impairment (MMSE <24) with a similar trend at 5 years, and ACS outcomes were more similar to minor stroke. Memory and language versus frontal/executive subtests were relatively more impaired in ACS than TIA and minor stroke patients. Conclusions Risk of cognitive impairment after ACS is similar to minor stroke and higher than TIA with implications for clinical practice including consent and adherence with medication. Differences in cognitive domain performance suggest a greater role for degenerative brain pathology in ACS which may be linked to vascular risk profile and cardiac factors.